PSCH vs. IBB
Compare and contrast key facts about Invesco S&P SmallCap Health Care ETF (PSCH) and iShares Nasdaq Biotechnology ETF (IBB).
PSCH and IBB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PSCH is a passively managed fund by Invesco that tracks the performance of the S&P SmallCap 600 Health Care Index. It was launched on Apr 7, 2010. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001. Both PSCH and IBB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PSCH or IBB.
Key characteristics
| PSCH | IBB | |
|---|---|---|
| YTD Return | 8.51% | 8.92% |
| 1Y Return | 19.37% | 18.40% |
| 3Y Return (Ann) | -9.19% | -4.98% |
| 5Y Return (Ann) | 3.45% | 7.45% |
| 10Y Return (Ann) | 9.78% | 5.11% |
| Sharpe Ratio | 0.86 | 0.97 |
| Daily Std Dev | 21.55% | 17.74% |
| Max Drawdown | -47.32% | -62.85% |
| Current Drawdown | -29.69% | -15.43% |
Correlation
The correlation between PSCH and IBB is 0.77, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
PSCH vs. IBB - Performance Comparison
The year-to-date returns for both investments are quite close, with PSCH having a 8.51% return and IBB slightly higher at 8.92%. Over the past 10 years, PSCH has outperformed IBB with an annualized return of 9.78%, while IBB has yielded a comparatively lower 5.11% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PSCH vs. IBB - Expense Ratio Comparison
PSCH has a 0.29% expense ratio, which is lower than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
PSCH vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PSCH vs. IBB - Dividend Comparison
PSCH's dividend yield for the trailing twelve months is around 0.23%, less than IBB's 0.27% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | 0.23% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 1.02% | 0.03% |
IBB iShares Nasdaq Biotechnology ETF | 0.27% | 0.26% | 0.31% | 0.21% | 0.21% | 0.17% | 0.20% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
PSCH vs. IBB - Drawdown Comparison
The maximum PSCH drawdown since its inception was -47.32%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for PSCH and IBB. For additional features, visit the drawdowns tool.
Volatility
PSCH vs. IBB - Volatility Comparison
Invesco S&P SmallCap Health Care ETF (PSCH) has a higher volatility of 4.77% compared to iShares Nasdaq Biotechnology ETF (IBB) at 4.12%. This indicates that PSCH's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.